Adjuvants Explained: Alum & Freund's in Immunology

The main differences between innate and adaptive immunity include: (1) Response time - innate is immediate while adaptive takes 3-5 days; (2) Cellular predominance - innate uses phagocytes and NK cells while adaptive uses lymphocytes; (3) Physical barriers - innate has skin, mucosa, and chemical barriers while adaptive relies on antibody secretion; (4) Specificity - innate has low specificity while adaptive has high specificity; (5) Diversity - innate has limited diversity while adaptive has broad diversity; (6) Memory - innate lacks memory while adaptive develops strong memory; (7) Resistance to reinfection - innate does not improve while adaptive increases resistance with repeated exposure.

Innate immunity is like fast-fit shoes - ready immediately but not perfectly tailored. Adaptive immunity is like custom-fit shoes - perfect but takes weeks to develop. Innate immunity provides immediate, non-specific defense and also provides the 'plan' for adaptive immunity. The innate system determines what type of adaptive response is needed (antibodies, cytotoxic T cells, helper T cells) based on infection type and severity. The adaptive immune system then executes this plan with high specificity. Without innate signals, adaptive immunity cannot be properly activated.

The immune system is divided into innate and adaptive immunity. Innate immunity is present from birth, non-specific, establishes rapidly within hours, is organ-specific, and has constant quantitative/qualitative responses. Its receptors do not undergo genetic reordering. Adaptive immunity requires 1-7 days to establish, is specific, generates memory, and its receptors originate from genetic reordering. Innate immunity uses pattern recognition receptors (PRRs) to recognize pathogen-associated molecular patterns (PAMPs) encoded in germline, while adaptive immunity uses antibodies and T-cell receptors generated through somatic recombination for specific antigen recognition.

The immune system comprises innate and adaptive immunity. Innate immunity is present at birth, hereditary, and includes macrophages and NK lymphocytes with low specificity. Adaptive immunity develops over time, includes B and T lymphocytes with high specificity, and generates immunological memory. Innate immunity responds rapidly with fagocytosis and complement activation, while adaptive immunity requires sensitization and produces antibodies (IgM, IgG, IgA, IgE, IgD) and cytotoxic T cells. The two systems interact, with innate cells activating adaptive responses and vice versa.

The immune response is divided into innate and adaptive immunity. Innate immunity provides immediate, pre-existing defense through physical barriers (skin, mucous membranes), phagocytes (macrophages, neutrophils), and the complement system. Adaptive immunity is slower but more specific, involving T and B lymphocytes that produce antibodies. Key differences include: innate immunity uses general receptors while adaptive immunity has high specificity for particular pathogen structures; innate immunity has no memory while adaptive immunity develops memory cells that improve response speed, potency, and magnitude upon repeated exposure. The immune system recognizes pathogens through PAMPs (Pathogen-Associated Molecular Patterns) and damaged cells through DAMPs (Damage-Associated Molecular Patterns). PAMPs include flagellin, LPS, lipoteichoic acid, and double-stranded DNA—structures absent in human cells. Pattern recognition receptors (PRRs) detect these patterns, located on cell membranes and inside cells. Toll-like receptors (TLRs) are a major class: TLR1/2 recognize lipopeptides, TLR4 recognizes LPS, TLR5 recognizes flagellin.

MHC (Major Histocompatibility Complex) is a gene cluster coding for cell surface proteins essential for immune recognition of foreign antigens in vertebrates. Antigen-presenting cells (APCs) like macrophages, dendritic cells, and leukocytes process foreign antigens through a three-step mechanism: antigens enter APCs and are engulfed into vesicles containing MHC molecules; vesicles fuse with the cell membrane, exposing MHC-antigen complexes on the surface; T cells then recognize these complexes using T cell receptors (TCRs), initiating immune responses. This process enables the immune system to distinguish self from non-self.

Antigen-presenting cells (APCs) process and present antigens through phagocytosis and lysosomal degradation. Pathogens are internalized into phagosomes that fuse with lysosomes to form phagolysosomes where proteases break down proteins into peptides. Only the most immunogenic epitopes are selected and loaded onto MHC molecules for presentation to T cells.

Professional antigen-presenting cells (APCs) including macrophages, dendritic cells, and B cells perform three key functions: (1) They recognize pathogens through surface receptors, (2) They engulf pathogens through phagocytosis, forming phagosomes, (3) They process pathogens by fusing lysosomes to break them into peptide fragments. These peptides then bind to MHC class II proteins, which transport the antigenic fragments to the cell surface for presentation to T cells. This process transforms simple pathogen recognition into a sophisticated antigen presentation system that activates the adaptive immune response.

Phagocytosis occurs through complement-dependent and antibody-dependent pathways. Complement-coated particles bind to macrophage complement receptors, while antibody-coated targets engage FcγRII receptors. After engulfment, phagolysosomes degrade pathogens with digestive enzymes. Antigen-presenting cells process captured antigens into peptides presented on MHC molecules: extracellular antigens on MHC class II for CD4+ T cell activation, intracellular antigens on MHC class I for CD8+ T cell activation. This antigen processing enables communication between innate and adaptive immune systems.

Antigen processing and presentation is a fundamental mechanism in adaptive immunity where antigens are degraded into peptides and displayed on cell surfaces via MHC molecules to activate T cells; the endogenous pathway processes intracellular antigens (like viral proteins) through proteasomes and TAP transporters for MHC class I presentation to CD8+ T cells, while the exogenous pathway processes extracellular antigens through phagocytosis and lysosomal degradation for MHC class II presentation to CD4+ T cells, with cross-presentation allowing dendritic cells to present exogenous antigens on MHC class I to CD8+ T cells.

Inflammation occurs through a coordinated physiological process: (1) Tissue-resident immune cells release vasodilators (histamine, prostaglandins) causing blood vessel dilation; (2) Endothelial cell gaps increase, allowing blood to rush to the infection site, causing redness and heat; (3) Increased vascular permeability causes plasma fluid to ooze into tissues, creating swelling; (4) Leukocytes escape through diapedesis into the infected area; (5) Activated immune cells secrete inflammatory mediators (cytokines, histamines, prostaglandins) that attract neutrophils and macrophages; (6) These cells phagocytose pathogens to clear the infection. This localized response eventually leads to tissue repair and restoration of homeostasis.

The inflammatory response is coordinated through cytokine release from macrophages and other cells. Cytokines recruit additional immune cells to the site of infection, activate resident cells, and promote tissue repair. This cytokine network ensures that the immune response is appropriately localized and regulated, preventing excessive tissue damage.

Immune cells are recruited to sites of inflammation or tissue damage through chemotactic signals. Cytokines and chemokines released by damaged or stressed cells attract immune cells from the bloodstream. These cells then exit the vasculature and migrate to the site of inflammation. This recruitment process is essential for effective immune surveillance and response.

The recruitment of immune cells to sites of inflammation is a coordinated process involving multiple cells and the microenvironment. Upon injury, tissue cells including resident immune cells and non-immune cells like fibroblasts release mediators such as vasodilators, cytokines, and chemokines. These act on the endothelium to create chemical gradients that attract neutrophils and monocytes. Adhesion molecules on endothelial surfaces serve as 'stop signs' for immune cells. Neutrophils interact with these molecules and transmigrate, primarily to eliminate threats. Monocytes follow, becoming tissue macrophages that eliminate microbes and dead tissue while also serving as sources of mediators that control inflammation and initiate adaptive immune responses.

When immune cells are activated by recognizing PAMPs via PRRs, they release important inflammatory cytokines including TNF-alpha (Tumor Necrosis Factor alpha), IL-1 beta (Interleukin 1 beta), and IL-6 (Interleukin 6). These cytokines act as signaling molecules that coordinate the inflammatory response throughout the body, recruiting additional immune cells and amplifying the immune reaction to combat infection.